Cite

HARVARD Citation

    Constanti, M. et al. (2021). Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk. Hypertension. 77 (2), p. . [Online]. 
  
Back to record